Sleep Apnea
Sunosi FDA Approved for Excessive Daytime Sleepiness in Patients with OSA and Narcolepsy
In a considerable industry breakthrough, Sunosi (solriamfetol), a new prescription medication has received FDA approval to treat excessive daytime sleepiness in patients with abnormal sleep patterns, such as obstructive sleep
January 20, 2021
8:06 am
